Skip to content

PMVP

PMV Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.50
+2.74%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+26.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 5, 2026LEVINE ARNOLD J · directorA-Award42,000$1.19
Jun 5, 2026Gallagher Carol Giltner · directorA-Award42,000$1.19
Jun 5, 2026FLOWERS KIRSTEN · directorA-Award42,000$1.19
Jun 5, 2026BAUM CHARLES M · directorA-Award42,000$1.19
Jun 5, 2026Stelzer Laurie · directorA-Award42,000$1.19
Mar 9, 2026Jalota Deepika · officer: Chief Development OfficerA-Award303,310$1.53
Mar 9, 2026Ticktin Robert · officer: General Counsel & COOA-Award319,270$1.53
Mar 9, 2026Carulli Michael · officer: Chief Financial OfficerA-Award240,000$1.53
Mar 9, 2026Mack David Henry · director, officer: President and CEOA-Award744,960$1.53
Oct 29, 2025Mack David Henry · director, officer: President and CEOM-Exempt220,643$1.37
Oct 27, 2025ORBIMED ADVISORS LLC · 10 percent ownerSale1,000,000$1.52
Sep 12, 2025ORBIMED ADVISORS LLC · 10 percent ownerSale500,000$1.80
Jul 3, 2025Mack David Henry · director, officer: President and CEOSale58,411$1.06
Jul 3, 2025Ticktin Robert · officer: General Counsel & COOSale23,151$1.06
Jul 3, 2025Jalota Deepika · officer: Chief Development OfficerSale33,065$1.06
Jul 3, 2025Carulli Michael · officer: Chief Financial OfficerSale28,249$1.06
Jun 9, 2025FLOWERS KIRSTEN · directorA-Award33,500$0.95
Jun 9, 2025BAUM CHARLES M · directorA-Award33,500$0.95
Jun 9, 2025Stelzer Laurie · directorA-Award33,500$0.95
Jun 9, 2025LEVINE ARNOLD J · directorA-Award33,500$0.95
Jun 9, 2025Heyman Richard A. · directorA-Award33,500$0.95
Jun 9, 2025Gallagher Carol Giltner · directorA-Award33,500$0.95
Mar 5, 2025Carulli Michael · officer: Chief Financial OfficerA-Award265,000$1.32
Mar 5, 2025Mack David Henry · director, officer: President and CEOA-Award800,000$1.32
Mar 5, 2025Jalota Deepika · officer: Chief Development OfficerA-Award300,000$1.32
Jan 22, 2025Mack David Henry · director, officer: President and CEOM-Exempt17,709$0.53
Jan 22, 2025Mack David Henry · director, officer: President and CEOM-Exempt91,750$0.53
Oct 3, 2024Carulli Michael · officer: Chief Financial OfficerA-Award40,805$1.48
Oct 3, 2024Mack David Henry · director, officer: President and CEOA-Award384,184$1.48
Oct 3, 2024Mack David Henry · director, officer: President and CEOA-Award330,000$1.48
Institutional positioning

13F filings over the trailing two quarters

New 19Increased 30Reduced 44Sold out 9
FilerActionSharesFiled
BML Capital Management, LLCIncreased5,330,000Aug 7, 2026
BML CAPITAL MANAGEMENT, LLCIncreased5,320,000May 6, 2026
TANG CAPITAL MANAGEMENT LLCUnchanged4,245,085Aug 14, 2026
TANG CAPITAL MANAGEMENT LLCReduced4,245,085May 15, 2026
SIO CAPITAL MANAGEMENT, LLCIncreased3,076,580May 14, 2026
ARROWMARK COLORADO HOLDINGS LLCReduced2,872,764May 15, 2026
Sio Capital Management, LLCReduced2,634,137Aug 14, 2026
EUCLIDEAN CAPITAL LLCUnchanged2,627,643May 15, 2026
Euclidean Capital LLCUnchanged2,627,643Aug 14, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased2,360,000Aug 14, 2026
EVERSEPT PARTNERS, LPNew Position2,348,360May 15, 2026
ACADIAN ASSET MANAGEMENT LLCUnchanged2,215,894Aug 13, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased2,215,894May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,012,020Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,974,906May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 5, 2026